Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiujun Cai

Showing results (231-240 of 299) with videos related to

Pageof 30
Sort By:
Frontiers in Cell and Developmental Biology|July 9, 2021
CircUBAP2 Promotes MMP9-Mediated Oncogenic Effect via Sponging miR-194-3p in Hepatocellular CarcinomaBoqiang Liu, Yuanshi Tian, Mingyu Chen, et al.
Heliyon|August 21, 2023
Global trends in research of mitophagy in liver diseases over past two decades: A bibliometric analysisJie Lin, Yushun Chang, Meiling Hu, et al.
Cancer Medicine|June 27, 2023
Estimating the influencing factors for T1b/T2 gallbladder cancer on survival and surgical approaches selectionJiasheng Cao, Jiafei Yan, Jiahao Hu, et al.
Experimental Cell Research|October 26, 2023
Corrigendum to "iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II" [Exp. Cell Res. 412, Issue 1, 1 March 2022, 113007]Junjie Hong, Yu-Shan Cheng, Shu Yang, et al.
Signal Transduction and Targeted Therapy|May 18, 2021
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinomaJunjie Xu, Lin Ji, Yeling Ruan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 14, 2024
Repeat laparoscopic liver resection after an initial open hepatectomyNasser Abdul Halim, Liang Xiao, Jingwei Cai, et al.
Cancer Letters|July 15, 2015
Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinomaJiang Chen, Renan Jin, Jie Zhao, et al.
Science Advances|February 19, 2019
Restriction of hepatitis B virus replication by c-Abl-induced proteasomal degradation of the viral polymeraseLidan Hou, Jie Zhao, Shaobing Gao, et al.
ILIVER|July 10, 2025
Identification of publication characteristics and research trends in the management of gallbladder cancerJiasheng Cao, Jiahao Hu, Jiliang Shen, et al.
Theranostics|August 6, 2020
LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcriptionZhongjie Lin, Shunjie Xia, Yuelong Liang, et al.
Pageof 30

Showing results (231-240 of 299) with videos related to

Sort By:
Pageof 30
Frontiers in Cell and Developmental Biology|July 9, 2021
CircUBAP2 Promotes MMP9-Mediated Oncogenic Effect via Sponging miR-194-3p in Hepatocellular CarcinomaBoqiang Liu, Yuanshi Tian, Mingyu Chen, et al.
Heliyon|August 21, 2023
Global trends in research of mitophagy in liver diseases over past two decades: A bibliometric analysisJie Lin, Yushun Chang, Meiling Hu, et al.
Cancer Medicine|June 27, 2023
Estimating the influencing factors for T1b/T2 gallbladder cancer on survival and surgical approaches selectionJiasheng Cao, Jiafei Yan, Jiahao Hu, et al.
Experimental Cell Research|October 26, 2023
Corrigendum to "iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II" [Exp. Cell Res. 412, Issue 1, 1 March 2022, 113007]Junjie Hong, Yu-Shan Cheng, Shu Yang, et al.
Signal Transduction and Targeted Therapy|May 18, 2021
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinomaJunjie Xu, Lin Ji, Yeling Ruan, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 14, 2024
Repeat laparoscopic liver resection after an initial open hepatectomyNasser Abdul Halim, Liang Xiao, Jingwei Cai, et al.
Cancer Letters|July 15, 2015
Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinomaJiang Chen, Renan Jin, Jie Zhao, et al.
Science Advances|February 19, 2019
Restriction of hepatitis B virus replication by c-Abl-induced proteasomal degradation of the viral polymeraseLidan Hou, Jie Zhao, Shaobing Gao, et al.
ILIVER|July 10, 2025
Identification of publication characteristics and research trends in the management of gallbladder cancerJiasheng Cao, Jiahao Hu, Jiliang Shen, et al.
Theranostics|August 6, 2020
LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcriptionZhongjie Lin, Shunjie Xia, Yuelong Liang, et al.
Pageof 30